Novanta Set To Replace Six Flax In S&P MidCap 400; Six Flax To Replace Natus Medical In S&P SmallCap 600
$NOVT
$NTUS
$SIX
Industrial Machinery/Components
Miscellaneous
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
Save time and jump to the most important pieces.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 5/15/2024 | $29.00 → $27.00 | Buy → Hold | Deutsche Bank | |
| 4/18/2024 | $30.00 → $31.00 | Neutral → Buy | B. Riley Securities | |
| 2/5/2024 | $30.00 | Buy → Neutral | B. Riley Securities | |
| 12/14/2023 | $29.00 → $32.00 | Equal-Weight → Overweight | Morgan Stanley | |
| 11/21/2023 | $32.00 → $25.00 | Buy → Neutral | Rosenblatt | |
| 11/20/2023 | $25.00 → $32.00 | Hold → Buy | Jefferies | |
| 11/3/2023 | $24.00 → $30.00 | Neutral → Buy | B. Riley Securities | |
| 11/3/2023 | $24.00 → $26.00 | Neutral → Buy | Citigroup |
SC 13G - NOVANTA INC (0001076930) (Subject)
SC 13G/A - NOVANTA INC (0001076930) (Subject)
SC 13G/A - Six Flags Entertainment Corp (0000701374) (Subject)
4 - NOVANTA INC (0001076930) (Issuer)
4 - NOVANTA INC (0001076930) (Issuer)
4 - NOVANTA INC (0001076930) (Issuer)
Sends Letter to Masimo Shareholders and Releases 160-Page Investor Presentation Urges Shareholders to Help Deliver Immediate Change by Voting for Both of Politan's Independent and Ideally Qualified Nominees Darlene Solomon and William Jellison on the WHITE Card Shareholders Can Visit www.AdvanceMasimo.com for Further Information Politan Capital Management (together with its affiliates, "Politan"), an 8.9% shareholder of Masimo Corporation ("Masimo" or the "Company") (NASDAQ:MASI), today sent a letter to the Company's shareholders outlining why a majority of truly independent directors are urgently needed in the Masimo boardroom. Politan also released a detailed investor presentation m
SAN MATEO, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced the appointment of Jonathan Kennedy to the role of Chief Financial Officer. In this role, Jonathan will be responsible for overseeing all financial management for the company, reporting directly to Chief Executive Officer Tony Chou. "Route 92 Medical's technology offers uniquely disruptive solutions in the rapidly growing stroke treatment market. The company is well-positioned for long-term growth, continued product innovation, and meaningful improvements in patient outc
Maintenance and engineering teams restructured into a single division to improve ride availability Six Flags Entertainment Corporation, the world's largest regional theme park company and largest operator of water parks in North America, today announced the appointment of Angus Jenkins to the newly created role of Vice President, Maintenance and Engineering. Jenkins and a team of four regional directors will lead the combined Maintenance and Engineering Division, supporting Six Flags' 27 properties with enhanced leadership, technical knowledge and on-going support. The new structure will position the Company to meaningfully improve ride availability at its properties over time, which is a
Novanta Inc. (NASDAQ:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer is scheduled to present at the Baird 2024 Global Industrial Conference on Wednesday, November 13, 2024, in Chicago, Illinois. About Novanta Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers a competitive advantage. We combine deep proprietary technology expertise and competencies in precision medicine and manufacturing, medical solutions, and robotics and automation with a proven ability to solve co
Novanta Inc. (NASDAQ:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third quarter 2024 results on Tuesday, November 5, 2024. The Company will host a conference call on Tuesday, November 5, 2024, at 10:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can be accessed online via a live webcast on the Events & Presentations page of the Investors section of the Company's website at www.novanta.com. A replay of the audio webcast will be available approximately three hours after the conclusion of the cal
Sends Letter to Shareholders Reiterating Why Voting for Both Politan's "Highly Credible and Capable" Nominees Is Essential in Order to Safeguard Shareholder Value and Realize Masimo's Potential Highlights Key Facts Brought to Light During Discovery Process and Remains Confident That Masimo's Frivolous Legal Claims and Efforts to Reject Politan's Nomination Notice Will Be Defeated Shareholders Can Vote for Politan's Independent Nominees, Darlene Solomon and William Jellison, on the WHITE Card and Can Visit www.AdvanceMasimo.com for Further Information Politan Capital Management (together with its affiliates, "Politan"), an 8.9% shareholder of Masimo Corporation ("Masimo" or the "Compan
Novanta Inc. (NASDAQ:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third quarter 2024 results on Tuesday, November 5, 2024. The Company will host a conference call on Tuesday, November 5, 2024, at 10:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can be accessed online via a live webcast on the Events & Presentations page of the Investors section of the Company's website at www.novanta.com. A replay of the audio webcast will be available approximately three hours after the conclusion of the cal
Second Quarter 2024 GAAP Revenue of $236 million Second Quarter 2024 GAAP Net Income of $13.8 million Second Quarter 2024 GAAP Diluted Earnings Per Share of $0.38 Second Quarter 2024 Adjusted Earnings Per Share of $0.73 Second Quarter 2024 Adjusted EBITDA of $51 million Novanta Inc. (NASDAQ:NOVT) ("Novanta" or the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the second quarter 2024. Financial Highlights Three Months Ended (In millions, except per share amounts) June 28, June 30, 2024 2023 GAAP
Novanta Inc. (NASDAQ:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its second quarter 2024 results on Tuesday, August 6, 2024. The Company will host a conference call on Tuesday, August 6, 2024, at 10:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can be accessed online via a live webcast on the Events & Presentations page of the Investors section of the Company's website at www.novanta.com. A replay of the audio webcast will be available approximately three hours after the conclusion of the call
Deutsche Bank downgraded Six Flags from Buy to Hold and set a new price target of $27.00 from $29.00 previously
B. Riley Securities upgraded Six Flags from Neutral to Buy and set a new price target of $31.00 from $30.00 previously
B. Riley Securities downgraded Six Flags from Buy to Neutral and set a new price target of $30.00
8-K - NOVANTA INC (0001076930) (Filer)
10-Q - NOVANTA INC (0001076930) (Filer)
8-K - NOVANTA INC (0001076930) (Filer)
Novanta's (NYSE:NOVT) short percent of float has risen 4.95% since its last report. The company recently reported that it has 1.57 million shares sold short, which is 5.73% of all regular shares that are available for trading. Based on its trading volume, it would take traders 16.25 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises. Short interest is im
Users Can Collect Coastercoin For Rewards At Physical Parks, Blending Virtual And Physical Worlds; Marks Major Milestone In Digital Transformation